NEW YORK, Oct. 4, 2018 /PRNewswire/ -- ARYA Sciences
Acquisition Corp. ("ARYA" or the "Company"), announced today that
it priced its initial public offering of 12,500,000 units at
$10.00 per unit for aggregate gross
proceeds of $125,000,000. The
sponsor of ARYA is ARYA Sciences Holdings, which is controlled by
principals of Perceptive Advisors, LLC. The Company has
granted the underwriters a 45-day option to purchase up to an
additional 1,875,000 units to cover over-allotments, if any.
The units are expected to begin trading on The Nasdaq Capital
Market on October 5, 2018 under the
symbol "ARYAU". Each unit consists of one Class A ordinary share
and one-half of one redeemable warrant, each whole warrant
entitling the holder thereof to purchase one Class A ordinary
share. No fractional warrants will be issued upon separation of the
units and only whole warrants will trade.
The offering is expected to close on October 10, 2018, subject to customary closing
conditions.
Jefferies LLC is acting as the sole book-running manager and
Chardan is acting as the lead manager for the offering.
A registration statement relating to these securities was
declared effective by the Securities and Exchange Commission on
October 4, 2018. The offering
will be made only by means of a prospectus. Copies of the
prospectus related to the offering may be obtained from Jefferies
LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison
Avenue, 2nd Floor, New York,
New York 10022, or by telephone at 877-547-6340, or by email
at Prospectus_Department@Jefferies.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About ARYA
We are a newly organized blank check company newly incorporated
as a Cayman Islands exempted
company for the purpose of effecting a merger, share exchange,
asset acquisition, share purchase, reorganization or similar
business combination with one or more businesses or entities.
We have not selected any business combination target and we have
not, nor has anyone on our behalf, initiated any substantive
discussions, directly or indirectly, with respect to identifying
any business combination target.
Forward Looking Statements
This press release includes forward-looking statements that
involve risks and uncertainties. Forward looking statements are
statements that are not historical facts. Such forward-looking
statements, including the successful consummation of the Company's
initial public offering, are subject to risks and uncertainties,
which could cause actual results to differ from the forward looking
statements. The Company expressly disclaims any obligations
or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change
in the Company's expectations with respect thereto or any change in
events, conditions or circumstances on which any statement is
based.
Contact
Michael Altman
Chief Financial Officer of ARYA Sciences Acquisition Corp.
(646) 205-5300
ARYA@perceptivelife.com
View original
content:http://www.prnewswire.com/news-releases/arya-sciences-acquisition-corp-prices-125-million-initial-public-offering-of-securities-300724966.html
SOURCE ARYA Sciences Acquisition Corp.